Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Interventional Diagnostic, Multicenter, Non-treatment Clinical Study Identifying Specific Molecular Changes by Using Genomic Sequencing Technologies in Refractory/Recurrent or Very High-risk Pediatric CNS Tumors.

NCT04859543 is registered in ClinicalTrials.gov with Masaryk University as lead sponsor.

NCT NCT04859543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04859543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Interventional Diagnostic, Multicenter, Non-treatment Clinical Study Identifying Specific Molecular Changes by Using Genomic Sequencing Technologies in Refractory/Recurrent or Very High-risk Pediatric CNS Tumors.
Lead sponsor
Masaryk University
Phase
Not applicable
Overall status
Completed
Start date
February 2, 2021
Completion date
December 10, 2024
Enrollment
80 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system neoplasms, gen1 gene mutation, pediatric cancer, tumor, brain